AstraZeneca to Supply 400 Million Doses of Vaccine in Europe by Year End

Reporter

6/13/2020|Updated: 6/14/2020

Biopharmaceutical company AstraZeneca has reached agreement with four European Union nations to supply up to 400 million doses of CCP virus vaccine by the end of 2020.

AstraZeneca, a drugmaker headquartered in Cambridge, England, struck the deal with Europe’s Inclusive Vaccines Alliance to supply vaccines currently being tested by the University of Oxford to Germany, France, Italy, and the Netherlands “at no profit.”

Venus Upadhayaya

Reporter

Venus Upadhayaya reports on India, China, and the Global South. Her traditional area of expertise is in Indian and South Asian geopolitics. Community media, sustainable development, and leadership remain her other areas of interest.

Author’s Selected Articles

China’s Footprint Is Clear in Kashmir Crisis, Analysts Say

Taiwan’s Tougher China Stance Should Bolster Support From Other Nations: Experts

On the Brink of a Multipolar World, India’s Grand Strategy Is Largely Defined by China, Analysts Say

CCP–Cook Islands Deal Raises Concerns for New Zealand, US, Australia